Instruction for use: Feloran

Active substance Diclofenac

ATX Code M02AA15 Diclofenac

Pharmacological group

NSAIDs - Acetic acid derivatives and related compounds

Nosological classification (ICD-10)

M05-M14 Inflammatory polyarthropathies

Arthropathies inflammatory, Inflammatory joint disease

M79.0 Other unspecified rheumatism

Degenerative rheumatic disease, Degenerative and rheumatic diseases of the tendons, Degenerative rheumatic diseases, Localized forms of rheumatism of soft tissues, Rheumatism, Rheumatism with a pronounced allergic component, Rheumatism of the articular and extraarticular, Rheumatic attack, Rheumatic complaints, Rheumatic diseases, Rheumatic disease of the spine, Relapses of rheumatism, Articular and extra-articular rheumatism, Articular and muscular rheumatism, Articular rheumatism, Articular syndrome with rheumatism, Chronic rheumatic pain, Chronic articular rheumatism, Rheumatoid diseases, Rheumatic diseases of the intervertebral disc

M79.1 Myalgia

Myofascial pain syndromes ,Pain syndrome in musculo-articular diseases, Pain syndrome in chronic inflammatory diseases of the musculoskeletal system, Pain in the muscles, Tenderness of muscles, Muscular soreness in severe physical exertion, Painful conditions of the musculoskeletal system, Pain in the musculoskeletal system, Pain in the muscles, Pain at rest, Muscle aches, Muscle pain, Musculoskeletal pain, Myalgia, Muscle pain, Muscle pain at rest, Muscle pain, Muscular pain of non-rheumatic origin, Muscle pain of rheumatic origin, Acute muscle pain, Rheumatic pain, Rheumatic pains, Myofascial syndrome, Fibromyalgia

T14.0 Surface injury of unspecified body region

Abrasions, Scratch, Skin Wounds, Wounds of soft tissues, Hematoma, Hematoma of traumatic origin, Hematomas, Hematomas of muscles, Hematomas of soft tissues, Healing of the skin, Bruise, Bruising due to sprains and bruises, Microtrauma, External bruises, Small combing, Superficial hematoma, Superficial damage to the skin and mucous membranes, Subcutaneous hematoma, Post-traumatic hematoma, Post-traumatic disturbance of microcirculation, Skinness of the skin, Traumatic plexus lesions, Injury, Contusion of soft tissues, Joint bruise, Traumatic bruises, Traumatic injury, Primary treatment of surface contaminated wounds, Abrasion, Bruise

T14.3 Dislocation, sprain and damage to the capsular-ligamentous apparatus of the joint of the unspecified area of the body

Painful stretching of muscles, Pain and inflammation in tension, Dislocation of dislocation, Degenerative changes in the ligamentous apparatus, Edema due to sprains and bruises, Edema after interventions for sprains, Damage and rupture of ligaments, The musculoskeletal system is damaged, Damage to ligaments, Damage to the joints, Ligament ruptures, Tendon tendons,Ruptures of the tendons of muscles,Stretching, Crick, Stretching of the muscle, Sprain, Tension of the tendons, Extensions,Stretch muscles, Sprains, Tension of the tendons, Injury of the musculoskeletal system, Injuries to the joints, Injuries of capsule-articular tissues, Injuries of the osteoarticular system, Injuries to ligamentsInjuries to the joints, Joint wounds, Stretching of the ligamentous apparatus, Habitual stretching and tearing

Composition and form of release

100 g of the gel contain diclofenac sodium 1 g; in tubes of 60 grams, in a box of 1 tuba.

pharmachologic effect

Pharmacological action - anti-inflammatory, decongestant, analgesic.

Relieves or eliminates pain at the site of application, reduces morning stiffness and swelling of the joints, helps increase the volume of movements.

Indication

Inflammatory and degenerative joint diseases; rheumatism and inflammatory edema of soft tissues; injuries, incl. bruises, sprains, ligaments, muscles and tendons; soreness of muscles and joints, caused by heavy physical exertion.

Contraindications

Hypersensitivity, bronchial asthma, provoked by the intake of NSAIDs; children under 2 years.

pregnancy and lactation

Contraindicated.

Side effects

Locally: burning sensation, allergic reactions, redness, rash, itching.

Dosing and Administration

Outer, 3-4 times a day; a small amount of gel is applied to the affected areas and rubbed into the skin with light movements.

Precautionary measures

With peptic ulcer of the stomach and duodenal ulcer in the phase of exacerbation, impaired renal function, bronchial asthma, allergic rhinitis, polyps of the nasal mucosa, with allergic reactions that occurred in the past, and before using the drug in children under 12 years old, consult a doctor.

Care should be taken when applying a large amount of gel to the vast surface of the skin for a long time. Do not use under airtight bandages or apply gel on open wounds and mucous membranes.

storage Conditions

In a dry place, at a temperature of 15-25 ° C.

Keep out of the reach of children.

Shelf life

2 years.

Do not use after the expiry date printed on the package.